KOLLTAN PHARMACEUTICALS INC — Form D/A

KOLLTAN PHARMACEUTICALS INC of NEW HAVEN, CT, a company, filed a Form D amendment with the SEC on 2010-09-16. The offering totals $7.5M, of which $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Thomas Peter NeffDirectorNew Haven, CT
Joseph Peter SchlessingerDirectorNew Haven, CT
Arthur G Altschul, Jr.Executive OfficerNew Haven, CT
K. Peter HirthDirectorSouth San Francisco, CA
Peter HirthDirectorSouth San Francisco, CA
E. Jonathan SoderstromDirectorNew Haven, CT
W. Bradford MiddlekauffExecutive OfficerExton, PA
Joseph SchlessingerDirectorWoodbridge, CT
Joseph SchlessingerPromoterWoodbridge, CT
Axel BolteDirectorBoston, MA
Gerald McMahonDirectorSouth San Francisco, CA
Gerald McMahonExecutive OfficerSouth San Francisco, CA
Jane Pritchett HendersonExecutive OfficerNew York, NY
Axel G BolteDirectorNew Haven, CT
Paul Jonathan MedeirosDirectorNew Haven, CT
Stanley Pritchett ChoyExecutive OfficerNew Haven, CT
Yaron Pritchett HadariExecutive OfficerNew Haven, CT
Theresa M LaValleeExecutive OfficerNew Haven, CT
Joseph B SchlessingerDirectorNew Haven, CT
Carolyn F SidorExecutive OfficerNew Haven, CT
Arthur G Altschul, Jr.DirectorNew Haven, CT
Arthur G Altschul, Jr.PromoterNew Haven, CT
Thomas B NeffDirectorSan Francisco, CA
Stanley Jonathan ChoyExecutive OfficerNew Haven, CT
Yaron Jonathan HadariExecutive OfficerNew Haven, CT

Other filings by this issuer (5)

FiledFormOfferingSold
2014-03-19D$60.0M$60.0M
2012-03-07D$25.0M$25.0M
2010-01-04D$2.5M$2.5M
2009-09-08D$7.5M$3.5M
2009-08-12D/A$40.0M$40.0M

More